January 5, 2022

VinFast Launches VinFirst NFT for EV’s Early-Bird Reservation

VinFast LOS ANGELES, Jan. 05, 2022 (GLOBE NEWSWIRE) — VinFast, the global electric vehicle (EV) brand owned by Vingroup – the largest private conglomerate in Vietnam with a total capitalization of 34.9 billion USD from three publicly traded companies (as of Nov 3, 2021) – has partnered with AAG Ventures and Harmony to announce a […]

>

Neeyamo Has Been Recognized as an Innovator in Avasant’s Global Hire-to-Retire Business Process Transformation 2021-22 RadarView

LOS GATOS, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) — Neeyamo Inc., a leading technology-enabled global payroll and HR services provider for multinational and micro-multinational corporations worldwide, has been recognized as an Innovator in Avasant’s maiden Global Hire-to-Retire Business Process Transformation 2021-22 RadarView. Avasant is a management consulting firm specializing in

>

Companies reduce emissions by up to 19% through digital tools, new report from Schneider Electric and CNBC shows

70% of emissions reduction are achievable with existing, proven and competitive technologies1 Swire Properties, IBM, Jacobs, IHG Hotels, and Tata Power share benefits of digital innovation Artificial intelligence, machine learning, blockchain, and 3-D modeling are key to supporting existing transformations as viable solutions to overcome climate challenges Rueil-Malmaison (France), January

>

Junshi Biosciences and DotBio Announce Collaboration to Develop Next-Generation Antibody Therapy with DotBody Module

SHANGHAI, China and SINGAPORE, Jan. 05, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biociences Co., Ltd (“Junshi Biosciences”, HKEX: 1877, SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and DotBio Pte. Ltd (“DotBio”), a biotech company specialized in next generation antibody therapies,

>

Conagen Successfully Develops Antioxidant Kaempferol by Precision Fermentation

Bedford, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) — Conagen, the Massachusetts-based biotechnology innovator, announced the successful development of antioxidant kaempferol produced by state-of-the-art, proprietary, precision fermentation. As a biotechnology company specializing in developing commercially valuable molecules for its partners and clients, Conagen’s kaempferol enables brands in nutrition, beauty, and personal

>